Evidence map›Paper›PMID 30334186›Full record

ArticleMolecular neurobiology2019

The Epigenetic Factor CBP Is Required for the Differentiation and Function of Medial Ganglionic Eminence-Derived Interneurons.

Alejandro Medrano-Fernández, Jose M Delgado-Garcia, Beatriz Del Blanco, Marián Llinares, Raudel Sánchez-Campusano, Román Olivares, Agnès Gruart, Angel Barco

Open access · hybridAbstract read
In one paragraph

Article in Molecular neurobiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Alejandro Medrano-FernándezInstituto de Neurociencias (Universidad Miguel Hernández - Consejo Superior de Investigaciones Científicas), Av. Santiago Ramón y Cajal s/n. Sant Joan d'Alacant. 03550, Alicante, Spain.
Jose M Delgado-GarciaDivision of Neurosciences, Pablo de Olavide University, 41013, Seville, Spain.
Beatriz Del BlancoInstituto de Neurociencias (Universidad Miguel Hernández - Consejo Superior de Investigaciones Científicas), Av. Santiago Ramón y Cajal s/n. Sant Joan d'Alacant. 03550, Alicante, Spain.
Marián LlinaresInstituto de Neurociencias (Universidad Miguel Hernández - Consejo Superior de Investigaciones Científicas), Av. Santiago Ramón y Cajal s/n. Sant Joan d'Alacant. 03550, Alicante, Spain.
Raudel Sánchez-CampusanoDivision of Neurosciences, Pablo de Olavide University, 41013, Seville, Spain.
Román OlivaresInstituto de Neurociencias (Universidad Miguel Hernández - Consejo Superior de Investigaciones Científicas), Av. Santiago Ramón y Cajal s/n. Sant Joan d'Alacant. 03550, Alicante, Spain.
Agnès GruartDivision of Neurosciences, Pablo de Olavide University, 41013, Seville, Spain.
Angel BarcoInstituto de Neurociencias (Universidad Miguel Hernández - Consejo Superior de Investigaciones Científicas), Av. Santiago Ramón y Cajal s/n. Sant Joan d'Alacant. 03550, Alicante, Spain. abarco@umh.es.ORCID http://orcid.org/0000-0002-0653-3751
Consejo Superior de Investigaciones Científicas · ESUniversidad Pablo de Olavide · ES

Funding

Generalitat Valenciana PROMETEO/2016/006Ministerio de Economía y Competitividad BFU2017-82375-RMinisterio de Economía y Competitividad PCIN-2015-192-C02-01Ministerio de Economía y Competitividad SAF2014-56197-RMinisterio de Economía y Competitividad SEV-2013-0317
6 · The paper itself

Abstract

The development of inhibitory circuits depends on the action of a network of transcription factors and epigenetic regulators that are critical for interneuron specification and differentiation. Although the identity of many of these transcription factors is well established, much less is known about the specific contribution of the chromatin-modifying enzymes that sculpt the interneuron epigenome. Here, we generated a mouse model in which the lysine acetyltransferase CBP is specifically removed from neural progenitors at the median ganglionic eminence (MGE), the structure where the most abundant types of cortical interneurons are born. Ablation of CBP interfered with the development of MGE-derived interneurons in both sexes, causing a reduction in the number of functionally mature interneurons in the adult forebrain. Genetic fate mapping experiments not only demonstrated that CBP ablation impacts on different interneuron classes, but also unveiled a compensatory increment of interneurons that escaped recombination and cushion the excitatory-inhibitory imbalance. Consistent with having a reduced number of interneurons, CBP-deficient mice exhibited a high incidence of spontaneous epileptic seizures, and alterations in brain rhythms and enhanced low gamma activity during status epilepticus. These perturbations led to abnormal behavior including hyperlocomotion, increased anxiety and cognitive impairments. Overall, our study demonstrates that CBP is essential for interneuron development and the proper functioning of inhibitory circuitry in vivo.

Indexed as

Epigenesis, GeneticAction PotentialsAnimalsAnxietyBehavior, AnimalCell DifferentiationChromosome MappingCognition DisordersEpilepsyFemaleHippocampusInterneuronsKainic AcidLearningMaleMedian EminenceKainic AcidMembrane ProteinsNkx2-1 protein, mousePag1 protein, mouseParvalbuminsPhosphoproteinsSomatostatinThyroid Nuclear Factor 1CBPEpilepsyIntellectual disabilityInterneuronsNeuroprogenitorRubinstein-Taybi syndrome

Identifiers

PMID30334186
PMCPMC6505511
OpenAlexW2896748259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.